Canaglifozin in the Diabetic-Obese and Poorly Controlled
Received Date: Oct 20, 2018 / Accepted Date: Nov 02, 2018 / Published Date: Nov 05, 2018
Abstract
Objective: To analyze the metabolic evolution in patients with previous poor control after starting treatment with canagliflozin.
Methodology: A retrospective observational study in patients with poor glycemic control assigned to several health centers of Albacete and Cuenca provinces in which treatment with canagliflozin has been started after 6 months. Variables are analyzed: age, sex, weight, height, BMI. Analytical variables: glycemia, glycated hemoglobin, total cholesterol, HDL, LDL, triglycerides, uric acid, C-reactive protein, urea, creatinine proteinuria
Results: 107 diabetic patients participated, 45.5% men, Average age 61, 16-23 years. Basal variable 6 months level signify Glucemia fasting 157.41-126.89, p>0.002 Hemoglobin glycated 8.55-6.91, p>0.003, Weight 84.31-80.21, p>0.002, BMI 31.66-30.04, p>0.04, Cholesterol T 199.05-188.61, p>0.03, LDL 113.36-97.102, p>0.05, TG 195.18-176.80, p>0.05.
Conclusion: The treatment with Canaglifozin 100 has been effective for the metabolic control of patients previously poorly controlled.
Keywords: Diabetes; Obesity; Bad control canaglifozina
Citation: Lopez PJT, Marcos FM, Marcos LT, Roldan CC, Albero JS, et al. (2018) Canaglifozin in the Diabetic-Obese and Poorly Controlled. Epidemiology (Sunnyvale) 8: 358. Doi: 10.4172/2161-1165.1000358
Copyright: © 2018 Lopez PJT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 2783
- [From(publication date): 0-2018 - May 19, 2024]
- Breakdown by view type
- HTML page views: 2136
- PDF downloads: 647
